RHÖN-KLINIKUM Aktiengesellschaft (XETRA:RHK) — Market Cap & Net Worth
Market Cap & Net Worth: RHÖN-KLINIKUM Aktiengesellschaft (RHK)
RHÖN-KLINIKUM Aktiengesellschaft (XETRA:RHK) has a market capitalization of $876.89 Million (€750.06 Million) as of September 16, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #9509 globally and #1178 in its home market, demonstrating a -0.68% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RHÖN-KLINIKUM Aktiengesellschaft's stock price €14.50 by its total outstanding shares 66938470 (66.94 Million). Also see how large is RHÖN-KLINIKUM Aktiengesellschaft's balance sheet for a full breakdown of the balance sheet.
RHÖN-KLINIKUM Aktiengesellschaft Market Cap History: 2015 to 2026
RHÖN-KLINIKUM Aktiengesellschaft's market capitalization history from 2015 to 2026. Data shows change from $2.01 Billion to $1.13 Billion (-4.55% CAGR). Also see RHÖN-KLINIKUM Aktiengesellschaft (RHK) cash conversion ratio for how efficiently the company converts equity into cash flow.
RHÖN-KLINIKUM Aktiengesellschaft Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RHÖN-KLINIKUM Aktiengesellschaft's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check RHÖN-KLINIKUM Aktiengesellschaft (RHK) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.68x
RHÖN-KLINIKUM Aktiengesellschaft's market cap is 0.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
25.09x
RHÖN-KLINIKUM Aktiengesellschaft's market cap is 25.09 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.01 Billion | $1.11 Billion | $85.38 Million | 1.81x | 23.55x |
| 2016 | $1.92 Billion | $1.18 Billion | $56.43 Million | 1.63x | 34.04x |
| 2017 | $2.27 Billion | $1.21 Billion | $35.15 Million | 1.87x | 64.47x |
| 2018 | $1.69 Billion | $1.23 Billion | $48.99 Million | 1.37x | 34.43x |
| 2019 | $1.35 Billion | $1.30 Billion | $43.28 Million | 1.04x | 31.24x |
| 2020 | $1.28 Billion | $1.36 Billion | $1.45 Million | 0.94x | 879.40x |
| 2021 | $1.11 Billion | $1.40 Billion | $28.30 Million | 0.79x | 39.30x |
| 2022 | $1.18 Billion | $1.45 Billion | $25.14 Million | 0.82x | 47.06x |
| 2023 | $782.58 Million | $1.73 Billion | $38.71 Million | 0.45x | 20.22x |
| 2024 | $1.09 Billion | $1.60 Billion | $43.35 Million | 0.68x | 25.09x |
Competitor Companies of RHK by Market Capitalization
Companies near RHÖN-KLINIKUM Aktiengesellschaft in the global market cap rankings as of September 16, 2026. Review RHÖN-KLINIKUM Aktiengesellschaft tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to RHÖN-KLINIKUM Aktiengesellschaft by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #292 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #916 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1005 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1239 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #292 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $425.49 |
| #916 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.71 |
| #1005 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1239 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $264.51 |
RHÖN-KLINIKUM Aktiengesellschaft Historical Marketcap From 2015 to 2026
Between 2015 and today, RHÖN-KLINIKUM Aktiengesellschaft's market cap moved from $2.01 Billion to $ 1.13 Billion, with a yearly change of -4.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.13 Billion | +14.17% |
| 2025 | €993.88 Million | -8.63% |
| 2024 | €1.09 Billion | +39.00% |
| 2023 | €782.58 Million | -33.86% |
| 2022 | €1.18 Billion | +6.40% |
| 2021 | €1.11 Billion | -12.85% |
| 2020 | €1.28 Billion | -5.61% |
| 2019 | €1.35 Billion | -19.86% |
| 2018 | €1.69 Billion | -25.56% |
| 2017 | €2.27 Billion | +17.98% |
| 2016 | €1.92 Billion | -4.46% |
| 2015 | €2.01 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 15th, 2026 the market cap of RHÖN-KLINIKUM Aktiengesellschaft was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $876.89 Million USD |
| MoneyControl | $876.89 Million USD |
| MarketWatch | $876.89 Million USD |
| marketcap.company | $876.89 Million USD |
| Reuters | $876.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About RHÖN-KLINIKUM Aktiengesellschaft
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company also operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.